Lindsay Davies

Lindsay Davies is a highly experienced professional in the fields of cell and gene therapy, stem cell immunology, and medical device development. As Co-Founder of QVance and Chief Executive Officer and Founder of CellTherEx Consulting, Lindsay has a strong entrepreneurial background. In current roles as European Regional Secretary for the International Society for Cell & Gene Therapy and Chief Scientific Officer at NextCell Pharma AB, responsibilities include leadership and strategic direction in the development of innovative therapies. Lindsay's tenure at Karolinska Institutet spans from researcher to affiliated researcher, contributing significantly to academic knowledge, including work on oral mucosal lamina propria progenitor cells. Previous experience includes a position as a Medical Device Development Specialist at Finnish Red Cross Blood Service and various research roles at Cardiff University, culminating in a PhD in Orthopaedic Biochemistry. Education includes fellow status with The Higher Education Academy and extensive research experience related to progenitor cells and their therapeutic applications.